Ten-year single-center experience with treatment of primary diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
Miklos Acs, Michael Gerken, Ivana Savić, Max Mayr, Jozef Zustin, Pompiliu Piso
Topics & Concepts
Cytoreductive surgeryHyperthermic intraperitoneal chemotherapyMedicinePeritoneal mesotheliomaMesotheliomaChemotherapyIntraperitoneal chemotherapySurgeryInternal medicinePathologyCancerOvarian cancerOccupational and environmental lung diseasesIntraperitoneal and Appendiceal MalignanciesAbdominal Surgery and Complications